News

Latest news

Hide mandatory notifications of trade
  • Q1 2016 Interim Financial Report

    Financial .2016

    Bionor Pharma ASA
    Interim Financial Report
    1 January – 31 March 2016
    Unaudited

    11 May 2016

  • Update from the Board of Directors

    Financial .2016

    (Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) announces that the Board of Directors is currently reviewing the company’s strategy and financing plans and will announce any possible changes in due course in a stock exchange announcement.

  • Three Bionor Pharma Board members collectively resign

    Financial .2016

    (Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) today announced that Benedicte Fossum, Kirsten Drejer and Jerome B. Zeldis collectively resign with immediate effect as board members in Bionor Pharma ASA owing to a shareholder led change in company strategy.

  • CEO leaves his position

    Financial .2016

    (Oslo, Norway, 26 April 2016) Bionor Pharma ASA (OSE:BIONOR) today announced that Dr. David Horn Solomon and Bionor’s Board of Directors have agreed that Dr. David Horn Solomon will leave his position as Chief Executive Officer of Bionor Pharma ASA, owing to a shareholder led change in company strategy.

  • Bionor Pharma - Minutes from the Annual General Meeting 22 April 2016

    Financial .2016

    (Oslo, Norway, 22 April 2016) The Annual General Meeting of Bionor Pharma ASA (OSE:BIONOR) was completed today.

  • Proposal from the Nomination Committee to the Annual General Meeting 22 April 2016

    Financial .2016

    (Oslo, Norway, 19 April 2016) With reference to announcement of 31 March 2016, the Nomination Committee of Bionor has issued the attached statement regarding election of Board of Directors and Nomination Committee members.

  • Notice of Annual General Meeting 22 April 2016

    Financial .2016

    (Oslo, Norway, 31 March 2016) The Annual General Meeting 2016 of Bionor Pharma ASA will be held on Friday 22 April 2016 at 12:00 hours at Hotel Continental, Stortingsgaten 24/26, Oslo, Norway, “Møterom 4”.

  • Annual Report 2015

    Financial .2016

    Oslo, Norway, 31 March 2016) The Board of Directors of Bionor Pharma ASA (OSE:BIONOR) today approved the Annual Report 2015.

  • Updated financial calendar 2016

    Financial .2016

    (Oslo, Norway, 31 March 2016) Bionor Pharma ASA (OSE:BIONOR) has changed the date for the Annual General Meeting and now scheduled its financial calendar for the remainder of 2016 as follows:

  • Updated Financial Calendar 2016

    Financial .2016

    (Oslo, Norway, 11 March 2016) Bionor Pharma ASA (OSE:BIONOR) has changed the date for the publication of the Annual Report 2015 and now scheduled its financial calendar for the remainder of 2016 as follows: